Publications by authors named "P Masaryk"

Claim this Profile
W
Wildlife-vehicle collision liability in Europe: A review of existing approaches and their implications.
M Bíl, L Balčiauskas, M Bílová, S Cellina, F Favilli, P Masaryk

J Environ Manage· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial.
Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opris, Reinhard Bos, Pavol Masaryk

Ann Rheum Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids.
Linda Hartman, José A P da Silva, Frank Buttgereit, Maurizio Cutolo, Daniela Opris-Belinski, Pavol Masaryk

Rheumatology (Oxford)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.
L Hartman, M El Alili, M Cutolo, D Opris, Jap Da Silva, P Masaryk

Semin Arthritis Rheum· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.
Maarten Boers, Linda Hartman, Daniela Opris-Belinski, Reinhard Bos, Marc R Kok, Pavol Masaryk

Ann Rheum Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis